Buy Breo Ellipta 100 ug/1 fluticasone furoate and vilanterol trifenatate

Breo Ellipta 100 ug/1 is a combination inhaler containing fluticasone furoate and vilanterol trifenatate. It is designed for respiratory use to help manage symptoms of certain lung conditions. This powder inhaler is manufactured by GlaxoSmithKline LLC in the USA.

Strength

100 ug/1

Pack Size

1 TRAY in 1 CARTON (0173-0859-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER

Manufacturer / TM Owner

GlaxoSmithKline LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Breo Ellipta 100 ug/1 is commonly used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The inhaler combines a corticosteroid and a long-acting beta-agonist to reduce inflammation and relax the muscles in the airways, making it easier to breathe. It is often prescribed for individuals who require both types of medication to manage their respiratory symptoms effectively.

Side Effects

When used as directed, Breo Ellipta 100 ug/1 may help improve lung function and reduce symptoms such as wheezing, shortness of breath, and coughing. Some users may experience common effects like headache, throat irritation, or a dry mouth. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

Breo Ellipta 100 ug/1 should be used with caution, especially by individuals with a history of heart conditions, high blood pressure, or thyroid problems. It is important to follow the prescribed dosage and administration instructions carefully. The inhaler should be stored at room temperature and kept away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Breo Ellipta 100 ug/1 may interact with certain medications, including other respiratory drugs, beta-blockers, and some antidepressants. It is important to avoid using this inhaler with other long-acting beta-agonists unless directed by a healthcare provider. Additionally, consuming alcohol while using this medication may increase the risk of side effects. Always consult a healthcare provider before starting any new medication.

References

Frequently Asked Questions

Breo Ellipta 100 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. It helps reduce inflammation and relax the muscles in the airways to improve breathing.

Breo Ellipta 100 ug/1 is a powder inhaler that should be used as directed by your healthcare provider. Follow the instructions provided with the inhaler to ensure proper administration.

Common side effects may include headache, throat irritation, and dry mouth. These effects are usually mild and temporary, but if they persist or worsen, consult a healthcare provider.

Breo Ellipta 100 ug/1 may interact with certain medications, so it is important to inform your healthcare provider about all the drugs you are taking to avoid potential interactions.

Store Breo Ellipta 100 ug/1 at room temperature and keep it away from moisture and heat. Always keep the inhaler in its original packaging until ready for use.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.